We are an emerging biopharmaceutical company
focused on innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders. Learn More
I’ve had migraines since I was 13...
my head feels like it’s going to explode, and with the nausea it’s hard to keep anything down, even water. It’s even hard to keep a pill down.” – Lori | Migraine Sufferer
We developed LAD for CNS patients,
including those battling Parkinson's disease, schizophrenia and bipolar disorder, who would benefit from improved control, consistency and convenience of long-term medication delivery. Learn More About LAD
Message from CEO Jane Hollingsworth
Millions of people live with neurologic diseases. Developing innovative neuroscience solutions to help these people is our core mission at NuPathe… Read More
adult Americans suffer from migraine.
American households includes an adult battling migraine
of migraineurs have nausea in at least half of attacks
Our Team
NuPathe is a collective of talented scientists and business professionals, all of whom are driving us to success.
Our Innovations
NP101 is an active, single-use transdermal sumatriptan patch that we are developing to relieve debilitating migraine headache pain and migraine-related nausea.
Our Recent News
01.19.12NuPathe Announces Allowance of Additional U.S. Patent Application for Its Migraine Patch Read More
Our Blog
Learn more about how NuPathe is working to address the treatment gaps of today’s patients, the biopharmaceutical business, and why we are driven to do what we do.